Stéphanie Forté: Gene Therapy in Sickle Cell Disease from Molecular Advances to Clinical Care
Stéphanie Forté, Principal Researcher at the Innovation Hub at the CHUM Research Center (CRCHUM), shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Very excited to share our new review on gene therapies in sickle cell disease, published in Cells:
The Journey of Gene Therapy in Sickle Cell Disease: How Molecular Advances Meet Clinical Care
Advances in gene therapy are ushering in a new era of hope for people living with sickle cell disease.
Our hope now is that these innovations become more equitably accessible worldwide.
The RED Network (Erythrocytes and Sickle Cell Network) continues to pursue this goal by strengthening international collaborations, patient registries, andclinical research in order to accelerate meaningful global progress for patients.”
Title: The Journey of Gene Therapy in Sickle Cell Disease: How Molecular Advances Meet Clinical Care
Authors: Magalie Tardif, Manon Saby, Stéphanie Forté, Thomas Pincez
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 6, 2026, 16:43Beth Shirley: Xylitol Consumption Increases Platelet Reactivity and Cardiovascular Risk
-
Oct 6, 2026, 16:37Jared Rice: What Sets the Transfusion Threshold in Anemia of Prematurity?
-
Oct 6, 2026, 16:30Thirunavukkarasu Angappan: Immunoglobulin Decides How Much Plasma Gets Collected
-
Oct 6, 2026, 16:18Gemma Davies: New CMML Research Selected for Presentation at the 68th ASH Annual Meeting
-
Oct 6, 2026, 16:03Professor Csongor Kiss Receives the Kálmán Laki Prize – Hungarian Society of Thrombosis and Haemostasis
-
Oct 6, 2026, 15:52Mark Kheifets: A Massive Stent Thrombosis Requiring Aspiration Thrombectomy
-
Oct 6, 2026, 15:40Joseph Aslan։ Targeting Mitochondrial Permeability Transition To Reduce Platelet Thrombogenicity
-
Oct 6, 2026, 15:36Nominations Open for ISTH Outstanding Mentor Awards – ISTH
-
Oct 6, 2026, 15:17Walaa Obaid: How Warfarin Went From Poison To Medicine